Literature DB >> 15093968

Add-on gabapentin in the treatment of opiate withdrawal.

José Martínez-Raga1, Ana Sabater, Bartolome Perez-Galvez, Miguel Castellano, Gaspar Cervera.   

Abstract

Gabapentin is an antiepileptic drug shown to be effective in the treatment of pain disorders and appears to be useful as well for several psychiatric disorders, including bipolar disorder, anxiety disorders, alcohol withdrawal and cocaine dependence. Gabapentin, at a dose of 600 mg three times a day, was evaluated as an add-on medication to a standard detoxification regime in seven heroin dependent individuals undergoing outpatient opiate withdrawal treatment. All seven patients successfully completed opiate detoxification and commenced opiate antagonist treatment with naltrexone on day five of withdrawal treatment, as scheduled. No adverse event was noted. Gabapentin appeared to lead a reduction in symptomatic medication and an overall beneficial effect on symptoms of heroin withdrawal.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15093968     DOI: 10.1016/j.pnpbp.2003.11.020

Source DB:  PubMed          Journal:  Prog Neuropsychopharmacol Biol Psychiatry        ISSN: 0278-5846            Impact factor:   5.067


  14 in total

Review 1.  Novel therapeutic strategies for alcohol and drug addiction: focus on GABA, ion channels and transcranial magnetic stimulation.

Authors:  Giovanni Addolorato; Lorenzo Leggio; F Woodward Hopf; Marco Diana; Antonello Bonci
Journal:  Neuropsychopharmacology       Date:  2011-10-26       Impact factor: 7.853

2.  Gabapentin completely attenuated the acute morphine-induced c-Fos expression in the rat nucleus accumbens.

Authors:  Jamil Ahsan Kazi; Mohamed Ibrahim Abu-Hassan
Journal:  J Mol Neurosci       Date:  2010-08-24       Impact factor: 3.444

Review 3.  Glutamatergic medications for the treatment of drug and behavioral addictions.

Authors:  M Foster Olive; Richard M Cleva; Peter W Kalivas; Robert J Malcolm
Journal:  Pharmacol Biochem Behav       Date:  2011-04-22       Impact factor: 3.533

4.  Consuming illicit opioids during a drug overdose epidemic: Illicit fentanyls, drug discernment, and the radical transformation of the illicit opioid market.

Authors:  Sarah E Duhart Clarke; Alex H Kral; Jon E Zibbell
Journal:  Int J Drug Policy       Date:  2021-10-15

5.  Gabapentin completely attenuated the acute morphine induced c-Fos expression in the rat striatum.

Authors:  Jamil Ahsan Kazi; Chen Fun Gee
Journal:  J Mol Neurosci       Date:  2007       Impact factor: 3.444

Review 6.  Glutamatergic substrates of drug addiction and alcoholism.

Authors:  Justin T Gass; M Foster Olive
Journal:  Biochem Pharmacol       Date:  2007-06-30       Impact factor: 5.858

Review 7.  Gabapentin for the treatment of alcohol use disorder.

Authors:  Barbara J Mason; Susan Quello; Farhad Shadan
Journal:  Expert Opin Investig Drugs       Date:  2017-12-23       Impact factor: 6.206

8.  Gabapentin Therapy in Psychiatric Disorders: A Systematic Review.

Authors:  Rachel K Berlin; Paul M Butler; Michael D Perloff
Journal:  Prim Care Companion CNS Disord       Date:  2015-10-22

9.  Pharmacological enhancement of naltrexone treatment for opioid dependence: a review.

Authors:  Paolo Mannelli; Kathleen S Peindl; Li-Tzy Wu
Journal:  Subst Abuse Rehabil       Date:  2011-06

10.  Development and validation of a rapid liquid chromatography/tandem mass spectrometry method to quantitate gabapentin and buprenorphine in human serum.

Authors:  Sarah J Phillips; Alison Oliveto; Michael J Mancino; Howard P Hendrickson
Journal:  Rapid Commun Mass Spectrom       Date:  2021-07-31       Impact factor: 2.586

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.